IQVIA Holdings Inc. (IQV)

185,59 -2,10 (-1,12%) Al cierre: 4:00PM EST

IQVIA Holdings Inc.

4820 Emperor Boulevard
Durham, NC 27703
United States
919 998 2000
http://www.iqvia.com

Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 68.000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Ari Bousbib	Chairman, Pres & CEO	8,93M	N/A	1961
Mr. Eric M. Sherbet	Exec. VP, Gen. Counsel & Sec.	1,11M	N/A	1964
Mr. W. Richard Staub III	Pres of R&D Solutions	1,38M	2,64M	1963
Mr. Kevin C. Knightly	Pres of Technology & Commercial Solutions	1,18M	5,16M	1961
Mr. Ronald E. Bruehlman	Exec. VP & CFO	N/A	N/A	1961
Mr. Emmanuel N. Korakis	Sr. VP, Corp. Controller & Principal Accounting Officer	N/A	N/A	1974
Dr. Jeffrey A. Spaeder	Sr. VP, Global Chief Medical & Scientific Officer	N/A	N/A	N/A
Mr. Alejandro Martinez	Chief Information Officer	N/A	N/A	N/A
Andrew Markwick	Sr. VP of Investor Relations & Treasury	N/A	N/A	N/A
Ms. Trudy Stein	Chief HR Officer & Exec. VP	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2019 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support services; and strategic planning and design services, as well as clinical trial, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. The company has a strategic alliance with ACCORD-2 to provide single research platform to speed development of new COVID-19 treatments. IQVIA Holdings Inc. serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Gobierno corporativo

El ISS Governance QualityScore de IQVIA Holdings Inc., a día 22 de enero de 2021, es 10. Las puntuaciones base son Auditoría: 1; Tablero: 10; Derechos de los accionistas: 10; Compensación: 10.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.